Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 16, 2016
Imaging Cytometry of Human Leukocytes with Third Harmonic Generation MicroscopyCheng-Ham Wu, Tzung-Dau Wang, Chia-Hung Hsieh, et al.
ACS Nano|November 8, 2011
Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapyTsai-Hua Chung, Jong-Kai Hsiao, Szu-Chun Hsu, et al.
Toxicology and Applied Pharmacology|March 27, 2010
The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cellsYing-Chun Chen, Jong-Kai Hsiao, Hon-Man Liu, et al.
Nanotechnology|May 19, 2010
Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cellsMicrosugar Chang, Jong-Kai Hsiao, Ming Yao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 19, 2005
Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell trackingDong-Ming Huang, Yann Hung, Bor-Sheng Ko, et al.
Plos One|September 18, 2015
Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective StudyShang-Yi Huang, Hsiu-Hsia Lin, Ming Yao, et al.
Nano Letters|January 11, 2007
Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labelingChen-Wen Lu, Yann Hung, Jong-Kai Hsiao, et al.
Biomaterials|April 11, 2009
The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticlesDong-Ming Huang, Jong-Kai Hsiao, Ying-Chun Chen, et al.
Journal of Hematopathology|January 4, 2024
Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapyJia-Rong Wu, Pei-Chun Shih, Ching Li, et al.
Pharmacological Research|October 5, 2023
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell deathChih-Peng Lin, Shu-Hui Wu, Tzu-Yin Lin, et al.
Pageof 5